Adel M. Nour
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Adel M. Nour has a total of 181 co-authors. Here are the top co-authors by number of shared publications:
Abraham Brass
17432 Alsin, Fredrik, 17460 Altamentova, Svetlana
1 shared publication- Adrienne Grzenda
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles
1 shared publication - Ahmed Bettaieb
Department of Nutrition, University of Tennessee Knoxville, Knoxville, TN 37996-0840, USA
1 shared publication Aimee H. Marceau
17432 Alsin, Fredrik, 17460 Altamentova, Svetlana
1 shared publicationAlain Lecoq
17432 Alsin, Fredrik, 17460 Altamentova, Svetlana
1 shared publicationAlberto González-Novo
17432 Alsin, Fredrik, 17460 Altamentova, Svetlana
1 shared publication
Latest Publications
- Open Access
- 20 June 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (6) , e0218091
Blocking transmembrane219 protein signaling inhibits autophagy and restores normal cell death
Autophagy plays a vital role in tumor therapy and survival of dormant tumor cells. Here we describe a novel function of a protein known as Transmembrane 219 (TM219) as an autophagy activator. TM219 is a small membrane protein expressed in all known human tissues except the thymus. We used biochemical approaches to identify calmodulin and calmodulin dependent protein kinase II as a part of TM219 protein complex. Then, we employed in vitro reconstitution system and fluorescence anisotropy to study the requirements of TM219 to bind calmodulin in vitro. We also used this system to study the effects of a synthetic peptide derived from the sequence of the short cytoplasmic tail of TM219 (SCTT) on calmodulin-TM219 receptor interactions. We conjugated SCTT peptide with a pH Low Insertion peptide (pHLIP) for optimal cellular delivery. We finally tested the effects of SCTT-pHLIP on triple negative human breast cancer cells in three dimension culture. Our data defined a novel function of TM219 protein and an efficient approach to inhibit it.
- 20 June 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (6) , e0218091
Open AccessBlocking transmembrane219 protein signaling inhibits autophagy and restores normal cell death
Autophagy plays a vital role in tumor therapy and survival of dormant tumor cells. Here we describe a novel function of a protein known as Transmembrane 219 (TM219) as an autophagy activator. TM219 is a small membrane protein expressed in all known human tissues except the thymus. We used biochemical approaches to identify calmodulin and calmodulin dependent protein kinase II as a part of TM219 protein complex. Then, we employed in vitro reconstitution system and fluorescence anisotropy to study the requirements of TM219 to bind calmodulin in vitro. We also used this system to study the effects of a synthetic peptide derived from the sequence of the short cytoplasmic tail of TM219 (SCTT) on calmodulin-TM219 receptor interactions. We conjugated SCTT peptide with a pH Low Insertion peptide (pHLIP) for optimal cellular delivery. We finally tested the effects of SCTT-pHLIP on triple negative human breast cancer cells in three dimension culture. Our data defined a novel function of TM219 protein and an efficient approach to inhibit it.
- Open Access
- 14 November 2016
- Published by Springer Nature in Nature Communications
- Vol. 7 (1) , 13541
Correction: Corrigendum: IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses
Nature Communications 7: Article number: 12752 (2016); Published 15 September 2016; Updated 14 November 2016 The financial support for this Article was not fully acknowledged. The acknowledgements should have included the following: Yorgo Modis, PhD was supported by a senior research fellowship fromthe Wellcome Trust, grant no.
- 14 November 2016
- Published by Springer Nature in Nature Communications
- Vol. 7 (1) , 13541
Open AccessCorrection: Corrigendum: IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses
Nature Communications 7: Article number: 12752 (2016); Published 15 September 2016; Updated 14 November 2016 The financial support for this Article was not fully acknowledged. The acknowledgements should have included the following: Yorgo Modis, PhD was supported by a senior research fellowship fromthe Wellcome Trust, grant no.
- Open Access
- 1 June 2013
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 288 (24)
Author Index
- 1 June 2013
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 288 (24)
Open AccessAuthor Index